EPTAM launches company-wide manufacturing philosophy for medical device scale-up

By AI, Created 11:12 AM UTC, May 20, 2026, /AGP/ – EPTAM Precision Solutions has launched “Reliability Requires Rhythm,” a new operating philosophy aimed at improving transfer execution and repeatable manufacturing for complex medical products. The move comes as medtech and biotech makers face tighter timelines, tougher regulation and more supply chain risk during scale-up.

Why it matters: - Medical manufacturers are dealing with more complex products, faster commercialization timelines, heavier regulatory pressure and continued supply chain volatility. - The hardest part of the lifecycle is often moving from prototype to full production. - EPTAM is positioning its new operating model as a way to reduce risk in that transition.

What happened: - EPTAM Precision Solutions announced the launch of “Reliability Requires Rhythm,” a company-wide operational philosophy for new product introduction and transfer execution. - The company said the approach is designed to improve scalable, repeatable manufacturing performance in complex medical markets. - Mary Jo Sysko, vice president of commercial development at EPTAM, said transfer programs are increasing across the market and many problems emerge during scale.

The details: - EPTAM works with medical OEMs to industrialize complex components and assemblies. - The company’s capabilities include precision plastic injection molding, liquid silicone rubber molding, advanced plastic and metal machining, micro-machining, and automated production and inspection systems. - EPTAM supports programs from early design collaboration through validated, high-volume manufacturing. - The “Rhythm” philosophy formalizes earlier cross-functional integration, structured verification milestones, and tighter coordination between design-for-manufacturing, tooling development, automation, and quality systems. - EPTAM says the goal is to validate critical inputs before volume ramps, reduce variability, protect design intent, and limit disruption during validation and scale-up. - Steve Cardin, chief operating officer at EPTAM, said small disconnects become large problems when programs scale. - The approach spans EPTAM’s plastic injection molding, liquid silicone rubber molding, plastic machining, metal machining, micro-machining, and automated production and inspection systems. - EPTAM said automation is intended to reduce variability and reinforce quality, not just increase speed.

Between the lines: - The launch reflects a broader shift in medtech manufacturing toward process discipline before production ramps, not after defects appear. - EPTAM is linking operational consistency to quality and resilience, which can matter as customers push for faster launches with less tolerance for rework or delay. - The message also suggests EPTAM wants to be seen as a scale-up partner, not just a parts supplier.

What’s next: - EPTAM said the new philosophy will guide how the company handles future transfer programs and scale-up work. - The company is framing the approach as part of its effort to help medical manufacturers bring more complex products to market with greater control and repeatability. - EPTAM’s social media presence includes its LinkedIn page. - Frazier Healthcare Partners, EPTAM’s private equity backer, was listed in the release, along with a link to more information about Frazier.